"Prostatic Hyperplasia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
Descriptor ID |
D011470
|
MeSH Number(s) |
C12.294.565.500
|
Concept/Terms |
Adenoma, Prostatic- Adenoma, Prostatic
- Adenomas, Prostatic
- Prostatic Adenomas
- Prostatic Adenoma
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Hyperplasia".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Hyperplasia".
This graph shows the total number of publications written about "Prostatic Hyperplasia" by people in this website by year, and whether "Prostatic Hyperplasia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2016 | 3 | 0 | 3 |
2017 | 16 | 3 | 19 |
2018 | 19 | 1 | 20 |
2019 | 10 | 1 | 11 |
2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Prostatic Hyperplasia" by people in Profiles.
-
Impact of COVID-19 pandemic on lower urinary tract symptoms in patients with benign prostatic hyperplasia and predictors of urine retention in such patients. Low Urin Tract Symptoms. 2022 Jan; 14(1):41-46.
-
Healthcare lockdown resulted in a treatment backlog in elective urological surgery during COVID-19. BJU Int. 2021 07; 128(1):33-35.
-
[Paradigm shift in combination therapy during the COVID-19 pandemic]. Urologiia. 2021 03; (1):33-38.
-
Extensive impact of COVID-19 pandemic on pelvic floor dysfunctions care: A nationwide interdisciplinary survey. Neurourol Urodyn. 2021 02; 40(2):695-704.
-
Implementing telemedicine for the management of benign urologic conditions: a single centre experience in Italy. World J Urol. 2021 Aug; 39(8):3109-3115.
-
Urological activity at the time of COVID-19 pandemic: is there any difference between public and private field? Pan Afr Med J. 2020; 37:389.
-
Impact of COVID-19 outbreak on urology surgical waiting lists and waiting lists prioritization strategies in the Post-COVID-19 era. Actas Urol Esp (Engl Ed). 2021 Apr; 45(3):207-214.
-
The Effect of the Presence of Lower Urinary System Symptoms on the Prognosis of COVID-19: Preliminary Results of a Prospective Study. Urol Int. 2020; 104(11-12):853-858.
-
Endourology and Benign Prostatic Hyperplasia in COVID-19 Pandemic. Int Braz J Urol. 2020 07; 46(suppl.1):34-38.
-
Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in ageing male: A retrospective study of 18 cases. Int J Clin Pract. 2020 Aug; 74(8):e13574.